Medpace Holdings EBITDA 2014-2025 | MEDP
Medpace Holdings annual and quarterly EBITDA history from 2014 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Medpace Holdings EBITDA for the quarter ending March 31, 2025 was $0.120B, a 8.46% increase year-over-year.
- Medpace Holdings EBITDA for the twelve months ending March 31, 2025 was $0.486B, a 27.08% increase year-over-year.
- Medpace Holdings 2024 annual EBITDA was $0.476B, a 31.11% increase from 2023.
- Medpace Holdings 2023 annual EBITDA was $0.363B, a 20.63% increase from 2022.
- Medpace Holdings 2022 annual EBITDA was $0.301B, a 37% increase from 2021.
| Medpace Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $476 |
| 2023 | $363 |
| 2022 | $301 |
| 2021 | $220 |
| 2020 | $186 |
| 2019 | $151 |
| 2018 | $133 |
| 2017 | $103 |
| 2016 | $113 |
| 2015 | $93 |
| 2014 | $75 |
| 2013 | $91 |
| Medpace Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $120 |
| 2024-12-31 | $133 |
| 2024-09-30 | $120 |
| 2024-06-30 | $112 |
| 2024-03-31 | $111 |
| 2023-12-31 | $94 |
| 2023-09-30 | $92 |
| 2023-06-30 | $85 |
| 2023-03-31 | $92 |
| 2022-12-31 | $82 |
| 2022-09-30 | $84 |
| 2022-06-30 | $66 |
| 2022-03-31 | $69 |
| 2021-12-31 | $61 |
| 2021-09-30 | $59 |
| 2021-06-30 | $48 |
| 2021-03-31 | $53 |
| 2020-12-31 | $60 |
| 2020-09-30 | $51 |
| 2020-06-30 | $35 |
| 2020-03-31 | $40 |
| 2019-12-31 | $41 |
| 2019-09-30 | $35 |
| 2019-06-30 | $41 |
| 2019-03-31 | $34 |
| 2018-12-31 | $40 |
| 2018-09-30 | $30 |
| 2018-06-30 | $33 |
| 2018-03-31 | $30 |
| 2017-12-31 | $18 |
| 2017-09-30 | $29 |
| 2017-06-30 | $28 |
| 2017-03-31 | $28 |
| 2016-12-31 | $28 |
| 2016-09-30 | $28 |
| 2016-06-30 | $29 |
| 2016-03-31 | $28 |
| 2015-12-31 | |
| 2015-09-30 | $7 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.225B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.821B | 26.97 |
| CVS Health (CVS) | United States | $84.326B | 10.48 |
| Elevance Health (ELV) | United States | $78.255B | 10.10 |
| Cencora (COR) | United States | $58.178B | 20.24 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.086B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.804B | 0.00 |
| Solventum (SOLV) | United States | $12.836B | 13.59 |
| CochLear (CHEOY) | Australia | $12.824B | 0.00 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.802B | 20.31 |
| Viatris (VTRS) | United States | $10.833B | 3.72 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| HealthEquity (HQY) | United States | $8.646B | 37.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
| BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
| Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
| Concentras Parent (CON) | United States | $2.619B | 15.13 |
| Organon (OGN) | United States | $2.576B | 2.74 |
| Progyny (PGNY) | United States | $2.038B | 44.87 |
| Ardent Health (ARDT) | United States | $1.981B | 8.45 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Premier (PINC) | United States | $1.778B | 13.49 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| CareDx (CDNA) | United States | $1.129B | 17.64 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| Nutex Health (NUTX) | United States | $0.643B | 9.73 |
| Embecta (EMBC) | United States | $0.619B | 4.17 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.546B | 0.00 |
| LifeMD (LFMD) | United States | $0.535B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| So-Young (SY) | China | $0.440B | 0.00 |
| Omada Health (OMDA) | $0.434B | 0.00 | |
| Enhabit (EHAB) | United States | $0.368B | 30.29 |
| Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.330B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Oncology Institute (TOI) | United States | $0.216B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.074B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |